Cargando…

Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?

BACKGROUND: Severe cutaneous adverse reactions to drugs (SCARs) include acute generalized exanthematous pustulosis (AGEP), drug reaction with eosinophilia and systemic symptoms (DRESS) and epidermal necrolysis (Stevens-Johnson syndrome–toxic epidermal necrolysis [SJS-TEN]). Because of the varied ini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouvresse, Sophie, Valeyrie-Allanore, Laurence, Ortonne, Nicolas, Konstantinou, Marie Pauline, Kardaun, Sylvia H, Bagot, Martine, Wolkenstein, Pierre, Roujeau, Jean-Claude
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517389/ https://www.ncbi.nlm.nih.gov/pubmed/23009177 http://dx.doi.org/10.1186/1750-1172-7-72

Ejemplares similares

Usefulness of patch tests in drug adverse reaction induced by tetrazepam and anti-inflammatory drugs
por: Assier, Haudrey, et al.
Publicado: (2014)

Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
por: Valeyrie-Allanore, Laurence, et al.
Publicado: (2014)

Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study
por: Lebargy, F., et al.
Publicado: (1997)

Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review
por: Zehou, Ouidad, et al.
Publicado: (2013)

AGEP overlap induced by hydroxychloroquine: a case report and literature review
por: Mercogliano, Christopher, et al.
Publicado: (2018)

Collagen sheet dressings for cutaneous lesions of toxic epidermal necrolysis
por: Bhattacharya, S., et al.
Publicado: (2011)

Recurrent Steven-Johnson/Toxic Epidermal Necrolysis Overlap Syndrome
por: Toledo-Martinez, Juan F, et al.
Publicado: (2022)

Patch testing in drug cutaneous adverse reactions: value of the extemporaneous preparations
por: Assier, Haudrey, et al.
Publicado: (2014)

Retrospective review of paediatric case reports of Stevens-Johnson syndrome and toxic epidermal necrolysis with lamotrigine from an international pharmacovigilance database
por: Egunsola, Oluwaseun, et al.
Publicado: (2017)

Aceclofenac induced Stevens-Johnson/toxic epidermal necrolysis overlap syndrome
por: Ameen, Kaderthambi Hajamohideen Nooru, et al.
Publicado: (2013)

Toxic Epidermal Necrolysis in an Irradiated Patient Treated with a Nanocrystalline Silver Dressing
por: Vern-Gross, Tamara Z., et al.
Publicado: (2012)

Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966
por: Bergqvist, Christina, et al.
Publicado: (2020)

Development and initial validation of a modified lymphocyte transformation test (LTT) assay in patients with DRESS and AGEP
por: Weir, Chris, et al.
Publicado: (2022)

Metabolic Tumour Burden Measured by (18)F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1
por: Van Der Gucht, Axel, et al.
Publicado: (2016)

Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe
por: Génin, Emmanuelle, et al.
Publicado: (2011)

Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)
por: Ingen-Housz-Oro, Saskia, et al.
Publicado: (2018)

Toxic Epidermal Necrolysis
por: Khalifian, Saami, et al.
Publicado: (2014)

Toxic epidermal necrolysis
por: Hoetzenecker, Wolfram, et al.
Publicado: (2016)

Acute generalized exanthematous pustulosis (AGEP) in Singapore
por: Lee, Haur Yueh, et al.
Publicado: (2014)

Skin Detachment and Regrowth in Toxic Epidermal Necrolysis
por: Feldmeyer, Laurence, et al.
Publicado: (2010)

Stevens–Johnson syndrome–toxic epidermal necrolysis (SJS–TEN) overlap associated with carbamazepine use
por: Suresh Kumar, P.N., et al.
Publicado: (2005)

Levofloxacin induced Stevens-Johnson syndrome/ toxic epidermal necrolysis overlap syndrome: case reports
por: Aversano, Maria Gloria, et al.
Publicado: (2014)

Review of Toxic Epidermal Necrolysis
por: Harris, Victoria, et al.
Publicado: (2016)

Toxic Epidermal Necrolysis and Sepsis
por: Alves, Daniela Dias, et al.
Publicado: (2016)

Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis
por: Qiu, Connie, et al.
Publicado: (2020)

Tolerance Induction to Antituberculosis Drugs in a Patient With Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Overlap
por: Collado-Chagoya, Rodrigo, et al.
Publicado: (2018)

Phenytoin-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlap in Focus: A Case Report
por: Puri, Piyush, et al.
Publicado: (2023)

Carbamzepine-induced toxic epidermal necrolysis
por: Chowta, Nithyananda K., et al.
Publicado: (2011)

Ofloxacin-induced toxic epidermal necrolysis
por: Gupta, Gaurang
Publicado: (2014)

Toxic epidermal necrolysis induced by lansoprazole()
por: Fracaroli, Tainá Scalfoni, et al.
Publicado: (2013)

Rapidly Developing Toxic Epidermal Necrolysis
por: Poulsen, Viktoria Oline Barrios, et al.
Publicado: (2013)

Toxic epidermal necrolysis in hemodialysis patient
por: Mateti, Uday Venkat, et al.
Publicado: (2015)

Early Manifestations of Toxic Epidermal Necrolysis
por: Chapman, James, et al.
Publicado: (2017)

Fulvestrant-induced toxic epidermal necrolysis
por: Morales-Conde, Macarena, et al.
Publicado: (2019)

Immune-Mediated Toxic Epidermal Necrolysis
por: Keerty, Dinesh, et al.
Publicado: (2020)

Allopurinol-Induced Toxic Epidermal Necrolysis
por: Buenrostro-Rubio, Ignacio, et al.
Publicado: (2019)

Toxic Epidermal Necrolysis Secondary to Metronidazole
por: Ali, Junaid, et al.
Publicado: (2021)

Pneumonia caused by toxic epidermal necrolysis
por: Doyle, Dominic, et al.
Publicado: (2022)

Pembrolizumab-Induced Toxic Epidermal Necrolysis
por: Borg, Luca, et al.
Publicado: (2022)

Multidisciplinary Treatment in Toxic Epidermal Necrolysis
por: Surowiecka, Agnieszka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1mpjil9oe0pk20o3cphdqspori